日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/08/22 | 7,150 | 7,190 | 7,130 | 7,170 | -20 | -0.3% | 84,600 |
2017/08/21 | 7,220 | 7,310 | 7,170 | 7,190 | -20 | -0.3% | 136,700 |
2017/08/18 | 7,180 | 7,290 | 7,140 | 7,210 | +30 | +0.4% | 187,100 |
2017/08/17 | 7,250 | 7,260 | 7,160 | 7,180 | -60 | -0.8% | 73,300 |
2017/08/16 | 7,180 | 7,240 | 7,140 | 7,240 | +100 | +1.4% | 127,600 |
2017/08/15 | 7,140 | 7,200 | 7,100 | 7,140 | +60 | +0.8% | 127,700 |
2017/08/14 | 7,070 | 7,140 | 6,960 | 7,080 | -50 | -0.7% | 199,700 |
2017/08/10 | 6,950 | 7,160 | 6,890 | 7,130 | +160 | +2.3% | 348,600 |
2017/08/09 | 6,930 | 7,010 | 6,850 | 6,970 | -110 | -1.6% | 251,000 |
2017/08/08 | 7,080 | 7,080 | 7,000 | 7,080 | +10 | +0.1% | 104,900 |
2017/08/07 | 7,150 | 7,150 | 7,020 | 7,070 | -30 | -0.4% | 93,600 |
2017/08/04 | 7,070 | 7,120 | 7,040 | 7,100 | +30 | +0.4% | 74,700 |
2017/08/03 | 7,120 | 7,150 | 7,020 | 7,070 | -50 | -0.7% | 91,000 |
2017/08/02 | 7,080 | 7,140 | 7,060 | 7,120 | +50 | +0.7% | 125,800 |
2017/08/01 | 6,970 | 7,080 | 6,930 | 7,070 | +100 | +1.4% | 128,800 |
2017/07/31 | 7,040 | 7,060 | 6,970 | 6,970 | -70 | -1% | 141,000 |
2017/07/28 | 7,100 | 7,110 | 7,020 | 7,040 | -70 | -1% | 117,400 |
2017/07/27 | 7,130 | 7,200 | 7,110 | 7,110 | -40 | -0.6% | 195,600 |
2017/07/26 | 7,280 | 7,280 | 7,100 | 7,150 | +50 | +0.7% | 177,900 |
2017/07/25 | 7,130 | 7,140 | 7,050 | 7,100 | -30 | -0.4% | 134,400 |
2017/07/24 | 7,180 | 7,270 | 7,090 | 7,130 | -80 | -1.1% | 150,300 |
2017/07/21 | 7,160 | 7,240 | 7,160 | 7,210 | +50 | +0.7% | 117,200 |
2017/07/20 | 7,070 | 7,180 | 7,070 | 7,160 | +90 | +1.3% | 73,500 |
2017/07/19 | 6,960 | 7,070 | 6,960 | 7,070 | +80 | +1.1% | 160,000 |
2017/07/18 | 7,020 | 7,040 | 6,950 | 6,990 | -30 | -0.4% | 146,800 |
2017/07/14 | 7,000 | 7,040 | 6,980 | 7,020 | -20 | -0.3% | 195,700 |
2017/07/13 | 7,000 | 7,090 | 6,970 | 7,040 | +10 | +0.1% | 160,600 |
2017/07/12 | 7,100 | 7,180 | 7,010 | 7,030 | -80 | -1.1% | 139,300 |
2017/07/11 | 7,050 | 7,110 | 7,040 | 7,110 | +70 | +1% | 109,000 |
2017/07/10 | 7,050 | 7,080 | 7,000 | 7,040 | +20 | +0.3% | 106,500 |
2017/07/07 | 7,040 | 7,100 | 6,980 | 7,020 | -110 | -1.5% | 156,100 |
2017/07/06 | 7,100 | 7,190 | 7,080 | 7,130 | +80 | +1.1% | 235,900 |
2017/07/05 | 7,070 | 7,080 | 6,970 | 7,050 | -20 | -0.3% | 178,700 |
2017/07/04 | 7,230 | 7,240 | 7,050 | 7,070 | -120 | -1.7% | 139,500 |
2017/07/03 | 7,230 | 7,240 | 7,170 | 7,190 | ±0 | ±0% | 164,300 |
2017/06/30 | 7,210 | 7,240 | 7,130 | 7,190 | -30 | -0.4% | 204,500 |
2017/06/29 | 7,230 | 7,270 | 7,170 | 7,220 | +20 | +0.3% | 156,500 |
2017/06/28 | 7,230 | 7,270 | 7,190 | 7,200 | -60 | -0.8% | 113,300 |
2017/06/27 | 7,260 | 7,320 | 7,220 | 7,260 | -30 | -0.4% | 155,900 |
2017/06/26 | 7,220 | 7,330 | 7,210 | 7,290 | +70 | +1% | 131,400 |
2017/06/23 | 7,230 | 7,260 | 7,180 | 7,220 | -10 | -0.1% | 153,300 |
2017/06/22 | 7,290 | 7,290 | 7,200 | 7,230 | ±0 | ±0% | 199,200 |
2017/06/21 | 7,270 | 7,310 | 7,210 | 7,230 | -70 | -1% | 238,700 |
2017/06/20 | 7,140 | 7,330 | 7,140 | 7,300 | +230 | +3.3% | 321,500 |
2017/06/19 | 7,000 | 7,120 | 6,990 | 7,070 | +90 | +1.3% | 140,300 |
2017/06/16 | 6,960 | 7,060 | 6,950 | 6,980 | +100 | +1.5% | 308,000 |
2017/06/15 | 6,830 | 6,930 | 6,830 | 6,880 | +90 | +1.3% | 179,800 |
2017/06/14 | 6,780 | 6,910 | 6,770 | 6,790 | +90 | +1.3% | 219,700 |
2017/06/13 | 6,670 | 6,730 | 6,640 | 6,700 | +30 | +0.4% | 127,800 |
2017/06/12 | 6,600 | 6,700 | 6,580 | 6,670 | +50 | +0.8% | 124,200 |
1901~
1950
件表示中 / 3714件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.84倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
ジーエヌアイ | 410,000円 | +21.7% | +999.9% | 0.00% | 17.17倍 | 5.68倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム